You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 5, MAY 1957 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hypotensive Reaction Following the Use of Glucagon

JOHN L. CARLETON, M.D.; STANLEY E. GREBEN, M.D.; JEROME L. SCHULMAN, M.D.

AMA Arch Intern Med. 1957;99(5):817-818.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There are no reported instances of sensitivity to glucagon. Recently we observed a severe hypotensive reaction immediately following the intravenous administration of glucagon. With the increased interest in glucagon, it appears advisable to report this reaction.

Report of Cases

The patient is a 52-year-old divorced housewife with a history of good physical health. Five years prior to this admission, on two separate occasions separated by two or three months, she received six to eight subcoma doses of insulin during psychiatric treatment at another location. Routine physical, neurological, and laboratory examinations at the time of admission to the Henry Phipps Psychiatric Clinic were within normal limits. Her diagnosis during this hospitalization was paranoid personality reaction.

The glucagon* was administered as a part of a study of the response to glucagon in a large group of persons. While the patient was in a fasting state and supine, a blood specimen was withdrawn . . . [Full Text PDF of this Article]


Author Affiliations

Baltimore

From the Department of Psychiatry of The Johns Hopkins Hospital.


Footnotes

Submitted for publication Oct. 8, 1956.

This investigation, under the direction of Dr. John C. Whitehorn, was supported by a research grant (M-1085) from the National Institute of Mental Health, of the National Institutes of Health, Public Health Service.

The glucagon employed in these studies was supplied by Dr. W. R. Kirtley, of Eli Lilly & Company.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1957 American Medical Association. All Rights Reserved.